News
Commit To Buy Recursion Pharmaceuticals At $7.50, Earn 32.7% Using Options May 31, 2024 — 11:39 am EDT Written by BNK Invest for BNK Invest -> ...
Recursion, a biotech company making new drugs using AI technology, just closed a $121 million Series C round with investors like the venture-capital firm Menlo Ventures.
Most AI-driven biopharma companies parse available data to find drug molecules that target single proteins believed to underlie a disease. This yields a lot of leads, but few pan out. Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback